These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6610423)

  • 1. Serotonin-releasing effects of substituted piperazines in vitro.
    Pettibone DJ; Williams M
    Biochem Pharmacol; 1984 May; 33(9):1531-5. PubMed ID: 6610423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
    Baumann MH; Rutter JJ; Auerbach SB
    Neuropharmacology; 1993 Dec; 32(12):1381-6. PubMed ID: 8152528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo.
    Fuller RW; Snoddy HD; Mason NR; Molloy BR
    Eur J Pharmacol; 1978 Nov; 52(1):11-6. PubMed ID: 720384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
    Nacca A; Guiso G; Fracasso C; Cervo L; Caccia S
    Br J Pharmacol; 1998 Dec; 125(7):1617-23. PubMed ID: 9884092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
    Tao R; Fray A; Aspley S; Brammer R; Heal D; Auerbach S
    Eur J Pharmacol; 2002 Jun; 445(1-2):69-81. PubMed ID: 12065196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of alpha-melanocyte-stimulating hormone release from superfused slices of rat hypothalamus by serotonin and the interaction of serotonin with the dopaminergic system inhibiting peptide release.
    Tiligada E; Wilson JF
    Brain Res; 1989 Dec; 503(2):225-8. PubMed ID: 2557964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct stimulatory effect of calcitonin on [3H]5-hydroxytryptamine release from the rat spinal cord.
    Bourgoin S; Pohl M; Hirsch M; Mauborgne A; Cesselin F; Hamon M
    Eur J Pharmacol; 1988 Oct; 156(1):13-23. PubMed ID: 2463177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.